Idexx Laboratories (IDXX) Enterprise Value (2009 - 2026)

Idexx Laboratories (IDXX) has reported Enterprise Value for 18 consecutive years, with -$200.5 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Enterprise Value fell 22.3% year-over-year to -$200.5 million; the TTM figure through Mar 2026 stood at -$200.5 million (down 22.3% YoY), while the FY2025 annual figure was -$180.1 million, up 37.53% from the prior year.
• Enterprise Value came in at -$200.5 million for Q1 2026 at Idexx Laboratories, down from -$180.1 million in the prior quarter.
• The five-year high for Enterprise Value was -$99.2 million in Q3 2022, with the low at -$453.9 million in Q4 2023.
• Average Enterprise Value over 5 years is -$227.9 million, with a median of -$200.5 million recorded in 2026.
• Across the five-year window, Enterprise Value plunged 303.33% in 2023 and soared 59.01% in 2025, its largest moves.
• Year by year, Enterprise Value stood at -$112.5 million in 2022, then slumped by 303.33% to -$453.9 million in 2023, then surged by 36.5% to -$288.3 million in 2024, then surged by 37.53% to -$180.1 million in 2025, then declined by 11.36% to -$200.5 million in 2026.
• According to Business Quant data, Enterprise Value over the past three periods registered -$200.5 million, -$180.1 million, and -$208.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.